You just read:

Exalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID® to Monitor Patients with Cirrhosis Associated with NASH

News provided by

Exalenz Bioscience

Aug 29, 2016, 08:00 ET